Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT. Journal of the American Society of Nephrology : JASN Chertow, G. M., Beddhu, S., Lewis, J. B., Toto, R. D., Cheung, A. K. 2016; 27 (1): 40-3

Abstract

In this manuscript, nephrologist-investigators from one of five Clinical Center Networks of the Systolic Blood Pressure Intervention Trial (SPRINT) provide background information and context on the intensity of anti-hypertensive therapy in conjunction with the release of detailed results from SPRINT's primary analysis. The authors highlight published evidence on the safety and efficacy of differing intensities of anti-hypertensive therapy in mild to moderate CKD, where SPRINT will help to inform practice, as well as where gaps in evidence will remain. The authors also challenge the nephrology community to renew its attention and efforts on hypertension clinical care and research.

View details for DOI 10.1681/ASN.2015101125

View details for PubMedID 26553785

View details for PubMedCentralID PMC4696594